Generex Biotechnology Corp. (GNBT)

Company Overview

Generex Biotechnology Corporation engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. It develops a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. The company’s primary product, Oral-lyn is an insulin spray formulation used for the treatment of Type-1 and Type-2 diabetes. It also develops Glucose RapidSpray that delivers glucose through a pump spray to the mouth, as well as morphine and fentanyl by oral formulation and injection for the treatment of moderate to severe breakthrough and postoperative pain. In addition, the...

read more

Watch the video to learn about the probability of Generex Biotechnology Corp. (GNBT) Chart Signal as of Apr 20 2014

Hotstocked Precision will calculate the probabilities of Generex Biotechnology Corp. (GNBT)

Rating:
Size: 656KB
Version: 1.1
Platform: Win/Mac
Downloads:
FREE DOWNLOAD

QUOTE

As of 08:13PM EDT April 20, 2014
$ 0.0355   0 (0%)
Today's Open: 0.0355 Previous Close: 0.0355
Today's High: 0.0355 Volume: 0
Today's Low: 0.0355 Avg Vol: 2,260,320
52 Week High: 0.056 Bid (size): 20,000
52 Week Low: 0.0235 Ask (size): 71,000

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: -
Mailing Address: 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2 Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANADA A1 M5J 2G2 4163642551
Phone: 416-364-2551
Fax: 416-364-9363
Website: http://www.generex.com

Company Details:

Symbol: GNBT
SIC: -
State location: A1
Sector: -
State of Inc: DE
Employees: 43
Type: OTCBB

Key executives:

Name Age Position
Anna E. Gluskin 63 Chairman, Chief Exec. Officer and Pres
Eric Von Hofe Ph.D. - Pres of Antigen Express
Gerald Bernstein M.D. 81 VP of Medical Affairs
Mark Fletcher Esq. 48 Exec. VP and Gen. Counsel
Rose C. Perri 47 Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer

Watch the video to learn about the probability of Generex Biotechnology Corp. (GNBT) Chart Signal as of Apr 20 2014

This free program will calculate the probabilities of Generex Biotechnology Corp. (GNBT) stock chart

Rating: Platform: Win/Mac
Price: FREE Version: 1.1
Size: 656KB Downloads:
FREE DOWNLOAD

LATEST ARTICLES

Generex Biotechnology Corp. (OTCMKTS:GNBT) With A Strong Start Of 2014 Jan 13, 2014

Generex Biotechnology Corp. (OTCMKTS:GNBT) With A Strong Start Of 2014 After fluctuating around $0.03 for the past four months the stock of Generex Biotechnology Corp. (OTCMKTS:GNBT) was finally able to break out. The start of the new year has brought a fresh dose of optimism and the ticker has been on a constant climb making just one red close out of the last eight sessions.read more

Generex Biotechnology Corporation (OTCMKTS:GNBT) Comes Under the Spotlight... Jan 7, 2014

Generex Biotechnology Corporation (OTCMKTS:GNBT) Comes Under the Spotlight Once Again Positive PR around Generex Biotechnology Corporation (OTCMKTS:GNBT) has been plentiful over the last couple of months. The company is now focused on getting the AE37 breast cancer vaccine on the market and if the announcements are to be believed, things seem to be going along nicely.read more

Generex Biotechnology Corp. (OTCMKTS:GNBT) Continues Upwards Jul 4, 2013

Generex Biotechnology Corp. (OTCMKTS:GNBT) Continues Upwards The fact that yesterday's market was cut in half did not stop the stock of Generex Biotechnology Corp. (OTCMKTS:GNBT) of having the best session for over a month. It added 12% to its value and for a brief moment in early trading touched upon $0.5 but subsided and at closing time was sitting at $0.039. Traded volume managed to reach substantial levels with 10 million shares shifted in the short span of the session.read more

Generex Biotechnology Corp.(OTCMKTS:GNBT) On Its Way To Recovery Jun 3, 2013

Generex Biotechnology Corp.(OTCMKTS:GNBT) On Its Way To Recovery After the slump they suffered back on May 24 Generex Biotechnology Corp. (OTCMKTS:GNBT) finally recovered some of the lost ground. A couple of tumultuous sessions followed after the fall to 3 cents per share. Finally last Friday the ticker recovered some lost ground when it surged by more than 21% to reach $0.36. Interest in the stock was also significant with 21 million shares traded at the end of the day.read more

Generex Biotechnology Corp. (OTCMKTS:GNBT) Ends the Week in the Red May 28, 2013

Generex Biotechnology Corp. (OTCMKTS:GNBT) Ends the Week in the Red Just before the weekend Generex Biotechnology Corp. (OTCMKTS:GNBT) slid down towards the bottom of the stock chart with nearly 20% to close at $0.031. Investors decided that the price levels are high enough and cashed in their holdings resulting in traded volume of more than 15 million shares. This came hot on the heels of several positive session that brought the ticker 30% up to as high as $0.0386.read more

LATEST STOCK PROMOTIONS

New product tease rewards TEGY traders with a 45% gain Dec 16, 2010, 15:52

    New product tease rewards TEGY traders with a 45% gain     TEGY Adds Some New Power Technologies to its Platform, and the Market Applauds! Good Afternoon! We knew that Transact Energy Corp. (TEGY) tends to make large and sudden moves, but this morning's 45% bounce was a lot more satisfying than we expected! After TEGY announced that it's talking about licensing read more

Promoter: BeaconEquity.com Paying Party: Unknown Max Profit: Pending Gain at close: Pending
Stock: GNBT Compensation: $50,000 Avg $ Volume for Period: UNKNOWN

=?WINDOWS-1252?Q?GNBT_is_being_accumulated_ Dec 16, 2010, 09:41

      GNBT is being accumulated – FAST!   Trade Alert: Generex Biotechnology Corp. (GNBT)   GNBT is 83% Off Recent Highs – But Now Reversing Course as FDA Approval is Sought!   Good Morning Hideout Trader!   The future of Generex Biotechnology Corporation (GNBT) which develops drug delivery systems and technologies is looking mighty bright again!   The read more

Promoter: Stock Hideout Paying Party: Unknown Max Profit: Pending Gain at close: Pending
Stock: GNBT Compensation: $90,000 BlueWave Advisors, LLC owns seventy five percent of the outstanding membership interests of StockHideout LLC. Stock_Analyzer owns twenty five percent of the outstanding membership interests of StockHideout, LLC. BlueWave Advisors has been compensated ninety thousand dollars from Emerging Equity Advisors, Inc. - non-controlling 3rd party sh Avg $ Volume for Period: UNKNOWN

PennyStockProphet - GNBT - Thursday! Dec 16, 2010, 09:20

PSP Members, I've got a bio-tech pick for us today that's picking up enormous momentum as it appears ready to bounce of it's 52-week low! This is a NASDAQ quality company currently trading at penny stock prices, and it's time to take advantage of it! The company's current 10-day trading average is over 1.3 Million shares per day and climbing! Volume has been picking up every day since Monday, and the company just announced yesterday a new patent read more

Promoter: Penny Stock Prophet Paying Party: UNKNOWN Max Profit: Pending Gain at close: Pending
Stock: GNBT Compensation: Unknown compensation Avg $ Volume for Period: UNKNOWN